This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of penis
C3_PENIS
penile neoplasm: Cancers or tumors of the PENIS or of its component tissues.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly males |
226754 |
2. Check conditionsNone |
226754 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
132 |
4. Check minimum number of eventsNone |
132 |
5. Include endpointsNone |
132 |
6. Filter based on genotype QC (FinnGen only) |
126 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of penis
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of penis, including Hilmo
- malignant neoplasm of male genital organs
- Solid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 126 | - | 126 |
| Unadjusted period prevalence (%) | 0.06 | - | 0.06 |
| Median age at first event (years) | 65.34 | - | 65.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 132
- Matched controls
- 1320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
121.3
97
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
70.2
61
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
66.4
58
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
58.8
52
*
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
51.5
46
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
40.8
37
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
40.8
37
*
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
+∞
40.8
37
*
KGB00
NOMESCO Finland
Biopsy of penis
536.4
40.4
38
*
JN4BD
NOMESCO Finland
Extensive body CT
18.7
39.8
35
25
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
72.1
39.7
44
9
JN4AD
NOMESCO Finland
Body CT examination
16.7
39.2
37
30
WX402
NOMESCO Finland
General anaesthesia
10.0
37.3
58
96
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
36.1
33
*
KGH10
NOMESCO Finland
Operation for phimosis
13.6
35.3
38
38
130
Kela drug reimbursment
Malignant tumour
+∞
31.5
29
*
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
28.1
26
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
10.6
26.9
34
42
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
25.9
24
*
KGD05
NOMESCO Finland
Partial excision of body of penis
+∞
24.8
23
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
290.6
24.5
24
*
H02AB02
ATC
dexamethasone; systemic
64.1
23.1
26
5
N48.1
ICD-10 Finland
Balanoposthitis
26.5
22.6
31
15
A03FA01
ATC
metoclopramide; systemic, rectal
9.2
21.8
30
41
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
21.4
20
*
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
+∞
20.3
19
*
B01AB10
ATC
tinzaparin; parenteral
9.7
19.5
25
31
UKC02
NOMESCO Finland
Cystoscopy
5.6
19.4
50
130
KGD96
NOMESCO Finland
Other partial excision of penis
+∞
19.2
18
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
19.2
18
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.0
18.3
28
43
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
7.0
18.0
32
58
ZXE10
NOMESCO Finland
More than one and less than three hours
4.7
17.6
71
262
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
17.0
16
*
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
+∞
17.0
16
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
17.0
16
*
116
Kela drug reimbursment
Prostate cancer
+∞
14.9
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
13.8
13
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.2
13.7
52
178
Z51.5
ICD-10 Finland
Palliative care
16.4
13.3
21
15
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.7
12
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
12.7
12
*
KDH10
NOMESCO Finland
Meatoplasty of urethra
143.0
12.7
13
*
XKD00
NOMESCO Finland
Uroflowmetry
3.9
12.4
50
177
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.6
12.3
26
55
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
25.7
11.9
16
7
ZZA00
NOMESCO Finland
Split skin graft
15.6
11.9
19
14
TKD00
NOMESCO Finland
Dilatation of urethra
71.5
11.8
13
*
KGC10
NOMESCO Finland
Total amputation of penis
+∞
11.6
11
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.7
11.5
21
21
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
10.7
48
180
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.6
10
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.6
10.3
45
166
WZC30
NOMESCO Finland
Teaching
4.2
9.9
31
90
TKC20
NOMESCO Finland
Catheterisation of bladder
5.2
9.7
22
49
WF049
NOMESCO Finland
Radiotherapy of metastasis
107.4
9.5
10
*
L03AA02
ATC
filgrastim; parenteral
107.4
9.5
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
9.5
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.5
9
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
9.5
9
*
N48.9
ICD-10 Finland
Disorder of penis, unspecified
39.6
9.2
11
*
A04AA01
ATC
ondansetron; systemic, rectal
17.8
8.7
13
8
JN4CD
NOMESCO Finland
Very extensive body CT
29.7
8.6
11
*
WX320
NOMESCO Finland
Spinalanesthesy
3.2
8.6
45
183
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
8.4
8
*
8070/3-C60.0
ICD-O-3
Squamous cell carcinoma, NOS, of prepuce
+∞
8.4
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
8.4
8
*
KGD10
NOMESCO Finland
Destruction of lesion of penis
35.8
8.2
10
*
N02AA05
ATC
oxycodone; systemic
3.7
8.2
30
97
WX240
NOMESCO Finland
Penis blockade
23.8
8.2
11
5
TPH07
NOMESCO Finland
Cathetrisation of artery
4.0
8.0
25
72
ZX120
NOMESCO Finland
Intravenous
4.9
8.0
19
44
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
12.9
7.8
13
11
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
6.8
7.7
19
32
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
7.7
30
101
R33
ICD-10 Finland
Retention of urine
3.7
7.7
28
90
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
14.5
7.5
12
9
N35.9
ICD-10 Finland
Urethral stricture, unspecified
14.5
7.5
12
9
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
84.6
7.5
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
84.6
7.5
8
*
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
84.6
7.5
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.0
7.4
23
66
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
7.4
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.4
7
*
8051/3-C60.9
ICD-O-3
Verrucous carcinoma, NOS, of penis, NOS
+∞
7.4
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.4
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.4
7
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
21.5
7.2
10
5
N48.8
ICD-10 Finland
Other specified disorders of penis
21.5
7.2
10
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
31.9
7.2
9
*
B01AB05
ATC
enoxaparin; parenteral
2.8
7.0
48
224
QBA10
NOMESCO Finland
Incision of skin of trunk
42.3
6.8
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
73.2
6.5
7
*
J01EA01
ATC
trimethoprim; systemic
3.6
6.4
23
73
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
6.3
6
*
N48.5
ICD-10 Finland
Ulcer of penis
+∞
6.3
6
*
KGW96
NOMESCO Finland
Other operation on penis
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
KGA10
NOMESCO Finland
Incision of prepuce
+∞
6.3
6
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
J01DB01
ATC
cefalexin; oral
3.4
6.3
112
825
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.3
6.2
14
21
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
6.2
31
121
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
7.9
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
90
379
5.32
19.24
3.4
2.3
—
—
—
0
0
103
546
5.03
14.86
5.9
3.4
20.67
405.78
e6/l
—
6
9
55
191
4.22
14.28
3.1
2.2
—
—
—
0
0
66
334
2.95
8.58
5.0
2.7
—
—
—
0
0
38
148
3.20
7.73
3.8
2.6
0.75
0.73
e6/l
0.02
22
85
81
486
2.73
7.22
16.9
17.9
1.38
1.42
inr
0.12
21
125
35
135
3.17
7.19
7.5
6.1
105.03
104.27
mmol/l
0.72
35
135
51
254
2.64
6.48
3.9
2.5
0.43
0.34
e6/l
0.18
39
190
101
700
2.89
6.43
10.8
5.4
78.90
74.71
u/l
0.56
96
647
26
93
3.24
5.99
2.2
2.9
—
—
—
0
0
71
426
2.44
5.95
9.2
6.0
1.19
1.20
mmol/l
0.73
59
369
35
156
2.69
5.43
3.6
2.5
1.80
1.20
e6/l
0.42
20
94
65
391
2.31
5.23
8.5
5.5
1.19
1.20
mmol/l
0.88
60
351
34
157
2.57
4.88
1.8
1.7
—
—
—
0
0
30
133
2.62
4.66
2.8
2.2
2.08
2.23
g/l
0.61
30
121
35
176
2.35
4.14
2.3
1.8
30.37
29.59
s
0.56
35
169
7
7
10.47
4.06
2.4
1.4
163.77
2.47
u/ml
—
7
7
101
798
2.13
3.38
28.2
14.7
15.49
15.07
%
0.25
101
782
71
497
1.93
3.38
15.5
6.2
4.82
4.38
e9/l
0.62
65
439
111
918
2.31
3.18
25.1
11.2
79.72
78.13
ml/min/173m2
0.28
98
757
62
426
1.86
3.03
5.6
4.0
0.00
0.00
estimate
—
10
68
61
423
1.82
2.85
3.9
3.0
0.00
0.01
estimate
—
10
73
62
435
1.80
2.77
4.0
3.0
0.00
0.00
estimate
—
9
61
23
115
2.21
2.71
1.8
1.6
—
—
—
0
0
16
69
2.50
2.60
1.8
1.6
—
—
—
0
0
22
113
2.14
2.43
1.9
1.8
—
—
—
0
0
8
22
3.80
2.40
1.5
1.2
—
—
—
0
0
112
965
2.06
2.34
26.9
12.6
33.82
26.45
mg/l
1.40
107
752
8
23
3.63
2.31
1.3
1.4
—
—
—
0
0
5
9
5.72
2.23
1.4
1.0
—
—
—
0
0
5
9
5.72
2.23
1.4
1.0
—
—
—
0
0
5
9
5.72
2.23
1.4
1.0
—
—
—
0
0
5
9
5.72
2.23
1.4
1.0
—
—
—
0
0
5
9
5.72
2.23
1.4
1.0
—
—
—
0
0
5
9
5.72
2.23
1.4
1.0
—
—
—
0
0
37
237
1.78
2.16
1.3
1.5
17.07
18.90
nmol/l
0.45
32
205
10
39
2.69
1.99
1.7
1.6
—
—
—
0
0
15
74
2.16
1.83
2.7
2.1
67.69
66.57
g/l
0.18
15
65
31
198
1.74
1.82
3.9
3.3
1.02
1.02
kg/l
0.12
12
26
116
1042
1.93
1.70
31.9
15.2
90.00
88.79
umol/l
0.12
116
1042
53
396
1.57
1.68
2.1
1.9
88.61
89.38
pmol/l
0.04
33
229
14
70
2.12
1.66
1.9
2.1
0.22
0.22
g/l
0.06
14
57
47
343
1.57
1.64
4.4
3.1
—
—
—
0
0
30
198
1.67
1.56
1.7
1.9
1023.87
1219.43
nmol/l
0.63
23
157
6
21
2.94
1.52
1.7
1.3
—
—
—
0
0
7
28
2.58
1.47
1.7
1.5
—
0.11
—
0
9
83
698
1.51
1.45
3.8
3.6
15.62
10.95
mm/h
1.62
77
641
5
16
3.20
1.45
1.0
1.2
—
—
—
0
0
5
16
3.20
1.45
1.6
1.5
—
—
—
0
0
5
16
3.20
1.45
1.0
1.2
—
—
—
0
0
5
17
3.01
1.37
1.4
1.2
—
—
—
0
0
6
127
0.45
1.25
6.2
8.2
—
—
—
0
0
8
37
2.24
1.24
1.8
1.5
—
—
—
0
0
5
19
2.69
1.22
4.6
3.6
68.00
30.59
mg/l
—
5
14
11
60
1.91
1.06
1.5
1.6
—
—
—
0
0
0
28
0.00
0.99
0.0
1.2
—
—
—
0
0
7
37
1.94
0.95
1.0
1.6
—
—
—
0
0
5
24
2.12
0.75
2.2
1.3
—
—
—
0
0
7
38
1.89
0.75
2.4
4.7
—
—
—
0
0
5
25
2.04
0.73
1.2
1.3
—
—
—
0
0
85
767
1.30
0.72
5.6
3.7
2.03
1.94
ug/l
0.14
76
682
115
1086
1.46
0.70
36.8
18.6
39.52
41.62
%
2.22
110
1012
115
1088
1.44
0.67
37.1
18.6
132.48
141.56
g/l
5.20
115
1063
5
29
1.75
0.64
1.6
1.5
—
—
—
0
0
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
11
74
1.53
0.55
2.7
1.5
381.64
373.17
nmol/l
0.04
11
64
9
61
1.51
0.55
1.6
1.4
—
—
—
0
0
102
965
1.25
0.45
4.6
4.6
6.21
6.16
mmol/l
0.16
94
861
18
227
0.76
0.45
1.6
1.9
456.89
385.94
pmol/l
0.63
18
192
5
32
1.58
0.42
1.0
1.7
—
—
—
0
0
25
206
1.26
0.42
4.0
3.8
416.90
548.71
ng/l
0.13
20
174
41
359
1.21
0.40
3.1
3.2
2254.12
1283.68
ng/l
0.78
36
307
17
136
1.29
0.36
4.8
4.6
28.82
30.27
%
0.20
11
94
56
510
1.17
0.35
1.9
2.5
—
—
—
0
0
6
45
1.35
0.34
1.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
3.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
11
90
1.24
0.20
2.2
1.9
—
—
—
0
0
27
244
1.13
0.18
4.8
3.1
0.00
0.05
estimate
—
10
61
99
1015
0.90
0.15
4.5
5.2
2.61
2.64
mmol/l
0.11
88
930
91
936
0.91
0.15
6.0
6.5
41.91
41.09
mmol/mol
0.36
78
863
61
637
0.92
0.14
3.0
2.9
14.20
15.05
pmol/l
2.00
55
556
46
438
1.08
0.11
3.7
3.9
47.04
55.38
ng/l
0.20
36
332
82
842
0.93
0.11
3.4
3.6
1.95
2.02
mu/l
0.23
70
748
12
106
1.15
0.10
4.7
3.4
6.05
5.74
kpa
0.62
12
99
34
355
0.94
0.07
4.9
4.3
13.93
11.27
mg/mmol
0.12
27
243
30
311
0.95
0.04
2.5
2.2
67.91
74.13
nmol/l
0.64
24
268
23
239
0.95
0.03
2.3
1.8
1.81
1.51
mmol/l
0.70
16
198
43
438
0.97
0.02
2.9
2.5
0.80
0.78
ug/l
0.03
27
274
62
613
1.02
0.01
4.8
3.6
20.32
24.73
%
1.10
31
269
99
989
1.00
0.00
4.9
4.6
4.49
4.42
mmol/l
0.24
89
908
99
985
1.02
0.00
4.3
4.6
1.24
1.31
mmol/l
1.33
87
898
96
965
0.98
0.00
4.5
4.1
1.57
1.37
mmol/l
1.47
86
876
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
12.62
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
59
0.84
-0.00
3.4
2.0
1.36
1.27
%
—
5
59
9
89
1.01
-0.00
1.4
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
61
0.98
-0.00
8.7
5.0
166.00
87.06
ng/l
—
6
55
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PENIS – Malignant neoplasm of penis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).